AI-ACCELERATED DRUG DISCOVERY

News & Blogs

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog thumbnail
July 2, 2025

Nobel Laureate Morten Meldal Joins Receptor.AI as Scientific Advisor

News
Read
News
Blog thumbnail
June 12, 2025

Receptor.AI Incorporates The REAXENSE Platform to Expand Full-Stack Drug Discovery Capabilities

News
Read
News
Blog thumbnail
April 9, 2025

AI vs Physics: Present and Future of PPI Structure Prediction Methods

Blogs
Read
Blogs
Blog thumbnail
April 2, 2025

Receptor.AI announces research collaboration with
ono Pharmaceutical

Partnership Announcement
Read
Partnership Announcement
Blog thumbnail
April 1, 2025

Receptor.AI Joins the Peptide Drug Hunting Consortium

News
Read
News
Blog thumbnail
February 10, 2025

Receptor.AI and Moexa Pharmaceuticals Partner to Advance AI-Powered SMAD3 Inhibitors

Partnership Announcement
Read
Partnership Announcement
Blog thumbnail
November 21, 2024

The Intersection of Generative AI and Molecular Dynamics in Drug Discovery: Limitations and Opportunities

Blogs
Read
Blogs
Blog thumbnail
November 8, 2024

Receptor.AI opens headquarters in boston, strengthening u.s. market presence

News
Read
News
Blog thumbnail
October 24, 2024

Receptor.AI and Reaxense Inc. Present Innovative AI-Driven Focused On-Demand Libraries for Drug Discovery

Partnership Announcement
Read
Partnership Announcement
Blog thumbnail
October 7, 2024

Introducing ArtiDock 2.5: NEXT-GEN Molecular Docking

News
Read
News
Blog thumbnail
October 3, 2024

Presenting the LLM-driven Workflow Orchestrator

News
Read
News
Blog thumbnail
September 10, 2024

Receptor.AI and Moexa Announce Research Collaboration to Discover Novel Therapeutics Targeting Protein-Protein Interactions (PPIs) for Cancer and Fibrosis Treatment

Partnership Announcement
Read
Partnership Announcement
Blog thumbnail
July 31, 2024

Designing protein proximity inducers with Receptor.AI drug discovery platform

Blogs
Read
Blogs
Blog thumbnail
June 11, 2024

Receptor.AI Marks Notable Presence at the ASCO and BIO International Convention 2024

Blogs
Read
Blogs
Blog thumbnail
June 7, 2024

AI Drug Discovery: Not One-Size-Fits-All – Addressing Data Challenges

Blogs
Read
Blogs
Blog thumbnail
March 19, 2024

Introducing ArtiDock 2.0: A New Era in AI-Driven Drug Discovery

News
Read
News
Blog thumbnail
March 13, 2024

Receptor.AI will attend Bio-Europe Spring Conference 2024

News
Read
News
Blog thumbnail
March 7, 2024

NVIDIA GTC Conference 2024 Presentation Announcement

News
Read
News
Blog thumbnail
December 1, 2023

Exciting News from the J.P. Morgan Healthcare Conference 2024

News
Read
News
Blog thumbnail
December 1, 2023

Receptor.AI Introduces ArtiDock

News
Read
News
Blog thumbnail
June 18, 2023

Receptor.AI Advances Design of Selective M3 Receptor Inhibitors

Blogs
Read
Blogs
Blog thumbnail
June 8, 2023

Unlocking the Potential of Cryptic Pockets with Receptor.AI

Blogs
Read
Blogs
Blog thumbnail
May 16, 2023

Redefining Precision: Introducing Receptor.AI’s 5-Level Compound Selectivity Platform

Blogs
Read
Blogs
Blog thumbnail
April 14, 2023

Benchmark of the AI-augmented structure-based activity and affinity prediction methods combined by a smart consensus function

Blogs
Read
Blogs
Blog thumbnail
March 31, 2023

The key for fast and efficient AI-assisted drug discovery: benchmarking the Receptor.AI ADME-Tox prediction model

Blogs
Read
Blogs
Blog thumbnail
March 17, 2023

Receptor.AI will attend Bio-Europe Spring Conference 2023

News
Read
News
Blog thumbnail
March 14, 2023

The rock-solid base for Receptor.AI drug discovery platform: benchmarking the drug-target interaction AI model

Blogs
Read
Blogs
Blog thumbnail
March 7, 2023

Podcast: Alan Nafiiev on Membranotropic Drug Discovery and the Future of AI in Pharma

Blogs
Read
Blogs
Blog thumbnail
February 7, 2023

Identification of dual-targeting Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learning

Blogs
Read
Blogs
Blog thumbnail
January 30, 2023

Developing bifunctional protein degraders for difficult-to-drug proteins with the Receptor.AI Platform

Blogs
Read
Blogs
Blog thumbnail
January 18, 2023

Receptor.AI introduces 3DProtDTA — the next-generation drug-target interaction AI model

Blogs
Read
Blogs
Blog thumbnail
January 8, 2023

Receptor.AI helps fight obesity by acting on the “sixth taste” receptors

Blogs
Read
Blogs
Blog thumbnail
January 8, 2023

The lipid membranes are druggable and available for AI-based drug design

Blogs
Read
Blogs
Blog thumbnail
September 23, 2022

AI meets DEL: Is this the most powerful combo in modern drug discovery?

Blogs
Read
Blogs
Blog thumbnail
August 15, 2022

Developing novel inhibitors of BRD4 to fight leukaemia with RECEPTOR.AI SaaS Platform

Blogs
Read
Blogs
Blog thumbnail
August 1, 2022

Data rules it all in AI-based drug discovery

Blogs
Read
Blogs
Blog thumbnail
April 20, 2022

Undruggable targets: the major challenge for modern drug discovery

Blogs
Read
Blogs
Blog thumbnail
December 9, 2021

AI contributes to understanding polypharmacology with explainable ML

Blogs
Read
Blogs
Blog thumbnail
November 19, 2021

The AI that speaks the language of chemical reactions natively

Blogs
Read
Blogs
Blog thumbnail
September 16, 2021

AI predicts interactions of the drugs having no clue about their chemical nature

Blogs
Read
Blogs
Drug discoveryPLATFORMABOUT US
CASE STUDIESScientific materialsNEWS
Contact us
© 2025 RECEPTOR AI | All Rights Reserved.
Privacy Policy
User Agreement